Oregon Grape Root 350mg – 90 Veg Caps


Oregon Grape root powder in a base of alfalfa, spirulina and bilberry.

Out of stock

Vegan, Kosher

Oregon grape has been used in the treatment of chronic skin conditions such as acne, psoriasis and eczema.

Potential applications: Diarrhoea, chronic candidiasis, conjunctivitis/blepharitis, gallstones, skin infections, parasites, poor digestion, psoriasis, urinary tract infections, cellular protection, trachoma, chronic cholecystitis and liver disorders. Inflammatory states of the mucus membranes, peptic ulcers, colitis, anorexia and painful menstruation.

Known contraindications: Not recommended for use during pregnancy and lactation. Use should be restricted for two to three week periods.

Interactions: It is suggested that the efficacy of certain drugs i.e. Doxycycline and Tetracycline may be reduced when taken in conjunction with Oregon grape. High doses may interfere with B vitamin metabolism.

Useful links: Acidophillus, grapefruit seed extract, fibre complex, l-glutamine, digestive aid, green food blend, Echinacea, dandelion/burdock.

Directions: As a food supplement, take one to three capsules daily with food, or as directed by your healthcare professional.

One vegetarian capsule provides:

Ingredient Weight %EC NRV
Oregon Grape root powder 350mg
in a base of alfalfa, spirulina and bilberry
As a food supplement take 1-3 capsules daily with food. Do not exceed stated dose unless recommended by your healthcare practitioner. Store in a cool dry place, out of the sight and reach of children. Not to be used during pregnancy or lactation unless recommended by a healthcare practitioner. This is a food supplement, not to be used as a substitute for a varied diet and lifestyle.
You can not claim for supplements that do not have nappi codes as these are not on the medical aids list of products.

DISCLAIMER: Product information correct at the time of publication. Viridian regularly updates product formulations in order to improve product efficacy, which can result in 2 or more concurrent formulation variations in our current stock.